Pelican Acquisition II

This registration defines the baseline economics, dilution profile, and governance constraints for public investors prior to capital deployment. It discloses extensive fiduciary conflicts, as Chairman Robert Labbe and director Daniel M. McCabe hold concurrent roles across multiple active and recently terminated blank check companies (including Yotta, Quetta, Black Hawk, Quartzsea, Quantumsphere, QuasarEdge, GalaxyEdge, and Pelican I/Greenland Energy), potentially limiting deal flow or incentivizing rushed combinations.

What changed: SEC Form 8-K Current Report and attached Exhibit 99.1 Press Release dated August 10, 2026. Pelican Acquisition II Corporation announced that, with underwriter consent, holders of units sold in the IPO may elect to separately trade the ordinary shares and rights included in the units, commencing on or about August 12, 2026. Unseparated units will continue trading under ticker 'PLCIU,' while separated ordinary shares and rights are expected to trade under 'PLCI' and 'PLCIR,' respectively. The company specified that holders must have their brokers contact Continental Stock Transfer & Trust Company to effect the split. Each unit comprises one ordinary share and one right to receive one-tenth (1/10) of one ordinary share. Why it matters: This is a routine administrative filing updating secondary market mechanics rather than signaling business combination progress or changes to redemption parameters. According to the press release, the company 'will not be limited to a particular industry or geographic region' in its efforts to identify a target and remains in a 'SEARCHING' status. Based on the provided filing tracker, the per-share trust value remains $10 and the liquidation deadline remains April 24, 2028, with no extension or termination discussed. Robert Labbe, listed as Chief Executive Officer, is cited as the corporate contact. No targets, partnership announcements, litigation, or financial metrics are disclosed.

What changed: A routine compliance exhibit (Form 8-K Current Report) and accompanying audited financial statements (Exhibit 99.1) disclosing the consummation of an initial public offering. According to the filing, Pelican Acquisition II Corporation consummated its IPO on July 27, 2026, issuing 8,625,000 units at $10.00 per unit for $86,250,000 in gross proceeds, including the full exercise of a 1,125,000-unit over-allotment option. The Company states that simultaneously, Sponsor Pelican II Capital Solutions Limited purchased 334,000 private placement units and underwriter EarlyBirdCapital, Inc. purchased 86,250 private placement units for an aggregate of $4,202,500. The Company places $87,112,500 into a trust account administered by Continental Stock Transfer & Trust Company, which the filing calculates as $10.10 per public share. The filing establishes a 21-month Combination Period, setting an April 27, 2028 deadline to consummate a business combination or trigger automatic winding up and liquidation. Underwriting compensation included a $1,725,000 cash discount paid to EarlyBirdCapital, plus a deferred $3,018,750 marketing service fee payable upon combination closure. The Sponsor advanced $235,000 to fund director and officer liability insurance and contractually agreed to be liable to the Company if third-party claims deplete the trust below $10.10 per public share. Management holds broad discretion over net proceeds but must target a business with an aggregate fair market value of at least 80% of trust assets at agreement. Founder shares were issued for $25,000 (approximately $0.0087 per share) and EBC founder shares for approximately $2,318. Public rights carry an estimated initial fair value of $1,293,750, or $0.15 per right, based on an implied ordinary share value of $9.85 and a 15.56% probability-weighted success assumption. The Sponsor may also provide up to $1,500,000 in working capital loans convertible to private units at $10.00 per unit. The Company changed its name from Pelican II Acquisition Corp to Pelican Acquisition II Corporation on March 18, 2026, and moved its fiscal year-end to June 30. Chief Executive Officer Robert Labbe signed the report. Why it matters: This filing establishes the exact redemptive floor ($10.10 per share) and the hard liquidation horizon (April 27, 2028), which directly governs when holders can demand trust distributions versus voting to extend the period. The documented fee stack ($1,725,000 immediate, $3,018,750 deferred, $15,000 monthly administrative services) and up-to-$1,500,000 convertible working capital facility detail the economic drag on the trust and potential dilution pathways if a deal closes or financing is extended. The Sponsor’s indemnification covenant and waiver of redemption/liquidation rights align insider capital with public shareholder outcomes. Auditor Simon & Edward, LLP’s explicit going concern disclaimer regarding execution timelines signals material operational risk independent of market conditions. Together, these mechanics dictate holder exit options, extension vote calculus, and sponsor fiduciary exposure ahead of the combination deadline.

What changed: 8-K filing reporting the closing of the initial public offering (IPO) of Pelican Acquisition II Corporation, a blank-check SPAC, including the entry into standard SPAC agreements (underwriting, trust, rights, registration, escrow, indemnification) and the adoption of the amended charter. The company completed its IPO of 8,625,000 units (including full exercise of the over-allotment) at $10.00 per unit, generating gross proceeds of $86,250,000. The trust account was funded with approximately $10.10 per public share (total ~$87.1 million). The amended charter was adopted, setting a 21-month deadline from the IPO closing (approximately April 27, 2028) to consummate a business combination. The initial board of directors was appointed (Robert Labbe, Daniel M. McCabe, Becky Fallon, Sean Michael Deegan). The sponsor and insiders are subject to lock-up restrictions: founder shares locked for 180 days post-business combination; private placement units locked for 30 days post-business combination. The over-allotment was fully exercised, so no forfeiture of founder shares occurred. Why it matters: This filing establishes the trust value per share at $10.10, the redemption mechanics, and the deadline for a business combination. Investors can now track the trust per share, monitor extension votes, and assess sponsor conduct. The IPO marks the start of the SPAC's search period, and the terms set the stage for any future deal.

What changed: Priced IPO of 7,500,000 units (8,625,000 with full over-allotment) at $10.00. Each unit is one ordinary share plus one right to receive one-tenth of one ordinary share commencing on consummation of the initial business combination; the offering includes no warrants. Trust: $10.10 per unit sold to the public, whether or not the over-allotment is exercised, at Continental Stock Transfer & Trust Company. The Combination Period is 21 months from consummation of the offering. EarlyBirdCapital, Inc. is sole book-running manager. Why it matters: The trust is overfunded at $10.10 per unit, above the $10.00 offering price, so the filed redemption floor starts above par and a $10.00 assumption would understate it. The sponsor and EarlyBirdCapital fund that overfunding directly: they buy private units at $10.00 in whatever amount is necessary to maintain $10.10 per public unit in trust, up to $3,340,000 with the over-allotment exercised in full. Extending the 21-month Combination Period requires a shareholder vote, and the prospectus states holders will be offered redemption in connection with it.

What changed: Form 8-A filed with the U.S. Securities and Exchange Commission to register Pelican Acquisition II Corporation’s units, ordinary shares, and rights under Section 12(b) of the Securities Exchange Act of 1934 for listing on The Nasdaq Stock Market LLC. The registrant formally registers three security classes: units, ordinary shares, and rights. According to Item 1, each unit consists of one ordinary share and one right, ordinary shares carry a par value of $0.0001 per share, and each right is exchangeable for one-tenth (1/10) of an ordinary share. Why it matters: Investors tracking redemption deadlines, trust value, extensions, deal progress, and sponsor conduct will note that this submission functions purely as an administrative listing confirmation. It advances no merger timeline, discloses no target due diligence, and leaves prior redemption parameters untouched. According to the signature block executed on July 23, 2026, Robert Labbe maintains the combined titles of CEO, CFO, and Chairman, confirming concentrated sponsor governance but offering no independent board oversight data.

What changed: S-1/A (Amendment No. 2) — amended SEC registration statement / preliminary prospectus for Pelican Acquisition II Corporation's proposed $75,000,000 SPAC initial public offering of 7,500,000 units at $10.00 per unit, each unit consisting of one ordinary share and one right to one-tenth of an ordinary share; no pricing date and no target identified. This amendment updates the registration statement with audited financial statements for the period February 26, 2026 (inception) through June 30, 2026, an auditor's report with a going-concern explanatory paragraph, the auditor's consent (Exhibit 23.3), and newly filed exhibits: the Sponsor subscription agreement (Exhibit 10.5), the EBC founder shares purchase letter (Exhibit 10.6), and the administrative services agreement (Exhibit 10.9). It does not introduce a new business combination or extension term; it reaffirms that the company has no target, has had no substantive target discussions, has a 21-month Combination Period from closing of the offering, and will deposit $10.10 per unit in trust ($75,750,000, or $87,112,500 if the over-allotment option is fully exercised). Why it matters: This is the operative initial public offering document for a blank-check company, setting the SPAC's core redemption and liquidation mechanics: public shareholders may redeem at trust value (initially $10.10 per public share) in connection with a business combination or an extension amendment; if no business combination closes within 21 months of the offering, the company redeems 100% of public shares and liquidates. It also details sponsor economics and conduct: the Sponsor paid $25,000 for 2,875,000 founder shares (up to 375,000 forfeitable), will buy 311,500 private units, and EarlyBirdCapital gets 200,000 EBC founder shares for $2,318 and will buy 75,000 private units, creating significant dilution and conflicts. The filing discloses $0 cash and a $131,684 working capital deficit at June 30, 2026, with substantial doubt about the company's ability to continue as a going concern, and extensive overlapping fiduciary duties of management to numerous other SPACs, which may affect target sourcing and deal timing.

What changed: Pelican Acquisition II Corporation's Amendment No. 1 to its registration statement on Form S-1 (File 333-296688), filed June 16, 2026. The registrant expressly labels it an exhibit-only filing: the prospectus narrative is unchanged and omitted, and the filing consists of the facing page, explanatory note, Part II Item 16 exhibit index, signature page, and the listed exhibits, including the underwriting agreement, charter documents, specimen certificates, rights agreement, legal opinions, trust agreement, insider letter, registration rights agreement, indemnity agreement, subscription agreement, private placement purchase agreements, escrow agreement, business combination marketing agreement, code of ethics, committee charters, clawback policy, and director consents. No business combination, redemption deadline, trust-per-share value, or prospectus disclosure was updated. The change is procedural and exhibit-related: the company is filing the complete exhibit package for the pending S-1, with Robert Labbe signing as CEO/Chairman and director consents from Daniel M. McCabe, Becky Fallon, and Sean Michael Deegan. The underwriting agreement filed as Exhibit 1.1 sets out proposed IPO terms: 7,500,000 units at $10.00 per unit, each unit comprising one ordinary share and one right, an over-allotment option of 1,125,000 units, a planned trust deposit of $75,750,000, 2,875,000 founder shares issued to the sponsor for $25,000 with up to 375,000 subject to forfeiture, and 386,500 private placement units at $10.00. The post-offering charter includes a 21-month period after the IPO to complete a business combination, subject to extension via an amendment that triggers public-share redemption. Why it matters: Although no redemption-calendar item moved, this filing establishes the SPAC's operative structure and confirms the company remains pre-target: the underwriting agreement states the company has no specific business combination under consideration and has not had substantive discussions with any target. It fixes key terms investors track, including the $10.00-per-unit offering, one-right-per-share unit structure, planned trust funding, tender-offer and redemption mechanics (including a minimum 20-business-day tender offer and a 15% group redemption cap in a shareholder-vote redemption), the 21-month completion window, the 80%-of-trust fair-value target threshold, sponsor and underwriter economics and lock-ups, and EarlyBirdCapital's 3.5% business-combination marketing fee plus a potential 1% finder fee. It is a pre-effective registration milestone, not a post-IPO deal or deadline event.

What changed: Registration statement (Form S-1) for an initial public offering of units, each consisting of one ordinary share and one right, by Pelican Acquisition II Corporation, a blank check company (SPAC) that is currently searching for a business combination target, with a primary focus on technology globally. This is a new S-1 registration statement; no prior public filing exists for this SPAC. The filing sets forth the terms of the proposed IPO: 7,500,000 units at $10.00 per unit, $10.10 per unit deposited into trust, a 21-month combination period from IPO closing, and private placements by the sponsor ($3,115,000) and underwriter ($750,000). The sponsor acquired 2,875,000 founder shares for $25,000 (approx. $0.0087/share). No target business has been identified or contacted. Why it matters: This filing establishes the core redemption mechanics, trust value, sponsor economics, and conflict-of-interest disclosures for the SPAC. Key items for investors: (1) trust per share is $10.10, not $10.00; (2) sponsor's nominal cost for founder shares creates a strong incentive to complete any deal; (3) a 15% cap on redemptions by any shareholder group if a vote is held; (4) CEO and directors serve on multiple other SPACs (Yotta, Quetta, Black Hawk, etc.), limiting available targets and creating conflicts; (5) the deadline is 21 months from IPO close – consistent with the user's estimated deadline of 2028-04-24.